Back to Search
DANIEL FELDMAN, MD
MD
Anesthesiology Physician
NPI: 1174815591IndividualAccepts Medicare
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
PMID 19547919·Invest New Drugs·2010
3-trial
Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
PMID 19513721·World J Urol·2009
6-review
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.
PMID 19224847·J Clin Oncol·2009
5-case
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
PMID 19494400·J Invasive Cardiol·2009
8-other
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma.
PMID 18501079·Clin Genitourin Cancer·2008
3-trial
Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
PMID 18073725·Nat Clin Pract Urol·2008
8-other
Presentation of low back pain in children had a low diagnosis rate.
PMID 18978437·J Bone Joint Surg Am·2008
8-other
Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
PMID 17892994·Am Heart J·2007
4-observational
Interobserver and intraobserver reliability in lower-limb deformity correction measurements.
PMID 17314647·J Pediatr Orthop·2007
8-other
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
PMID 17520176·Invest New Drugs·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 525 E 68TH ST
NEW YORK, NY 10065 - Phone
- (212) 746-2941
Quick Facts
- NPI
- 1174815591
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile